OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
Paolo Immovilli, Nicola Morelli, Chiara Terracciano, et al.
Neurology International (2022) Vol. 14, Iss. 2, pp. 368-377
Open Access | Times Cited: 6
Paolo Immovilli, Nicola Morelli, Chiara Terracciano, et al.
Neurology International (2022) Vol. 14, Iss. 2, pp. 368-377
Open Access | Times Cited: 6
Showing 6 citing articles:
Summary of safety and efficacy of COVID-19 vaccination in patients with multiple sclerosis
Eva Pernicová, Petra Macounová, Martin Krsek, et al.
European Neurology (2023) Vol. 86, Iss. 4, pp. 263-276
Open Access | Times Cited: 9
Eva Pernicová, Petra Macounová, Martin Krsek, et al.
European Neurology (2023) Vol. 86, Iss. 4, pp. 263-276
Open Access | Times Cited: 9
Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
Sepideh Paybast, Mohammad Amin Habibi, Abdorreza Naser Moghadasi
Neurological Sciences (2022) Vol. 44, Iss. 2, pp. 659-665
Open Access | Times Cited: 11
Sepideh Paybast, Mohammad Amin Habibi, Abdorreza Naser Moghadasi
Neurological Sciences (2022) Vol. 44, Iss. 2, pp. 659-665
Open Access | Times Cited: 11
The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
Maria Sofia Basile, Placido Bramanti, Emanuela Mazzon
Genes (2022) Vol. 13, Iss. 8, pp. 1319-1319
Open Access | Times Cited: 9
Maria Sofia Basile, Placido Bramanti, Emanuela Mazzon
Genes (2022) Vol. 13, Iss. 8, pp. 1319-1319
Open Access | Times Cited: 9
Clinical and Functional Evolution in Subjects with Parkinson’s Disease during SARS-CoV-2 Pandemic
Marianna Capecci, Nicolò Baldini, Francesca Campignoli, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 1126-1126
Open Access | Times Cited: 3
Marianna Capecci, Nicolò Baldini, Francesca Campignoli, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 1126-1126
Open Access | Times Cited: 3
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study
Harry Jin, Caroline K. Geiger, Nikki Jessop, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104943-104943
Closed Access | Times Cited: 3
Harry Jin, Caroline K. Geiger, Nikki Jessop, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104943-104943
Closed Access | Times Cited: 3
Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis
Rupali Mohite, Sankalp Gharat, Gaurav Doshi
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 10, pp. 1131-1145
Closed Access
Rupali Mohite, Sankalp Gharat, Gaurav Doshi
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 10, pp. 1131-1145
Closed Access
